The US Food and Drug Administration (FDA) has approved the Pfizer / Biontech vaccine against COVID-19 for children aged between 6 months and 4 years for emergency use, pharmaceutical companies said today.
Everything on the topic:
The coronavirus epidemic (COVID-19) 31641
The vaccine for this age group is given in three doses of 3 micrograms.
The emergency use permit is based on data from phase 2 and 3 of a controlled trial involving 4,526 children aged between 6 months and 4 years, the companies said.
Experts in the United States recommend vaccines against COVID-19 for the youngest
They said they would begin delivering pediatric doses as ordered by the US government.
The companies plan to apply for approval of their COVID-19 vaccine for this age group to regulators around the world, including the European Medicines Agency, in early July.
More about Coronavirus
latest: Check out the latest news
Easy Steps: How to Protect Yourself?
simple guide: What are the symptoms?
The Coronavirus Epidemic (COVID-19)